(AP) — Abbott Laboratories Inc. is expanding a study of its top-selling heart stent by more than 2,000 patients, who may also be put in a second, landmark stent study meant to find the best way to prevent potentially fatal blood clots. The bigger study aims to determine the optimum time ...
Copyright CRAIN - Crain's
